Loading...
Back to narrative

Update shared on08 Oct 2025

Fair value Decreased 16%
AnalystConsensusTarget's Fair Value
€85.10
40.0% undervalued intrinsic discount
08 Oct
€51.10
Loading
1Y
-49.6%
7D
-22.6%

Analysts have lowered their price target for SEB from €101.60 to €85.10, citing more severe-than-expected impacts from U.S. tariffs and revised assumptions for growth and profitability.

Analyst Commentary

Recent analyst revisions reflect a more cautious outlook for SEB, following increased exposure to U.S. tariffs and consequent impacts on the company's growth trajectory and profitability.

Bullish Takeaways

  • Bullish analysts believe SEB still has a strong underlying business model that can drive long-term growth, especially if global economic conditions stabilize.
  • There is confidence in the company's ability to adapt its supply chain and mitigate cost pressures over time. This could support improved margins in future periods.
  • SEB's established market presence and diversified product portfolio are viewed as key strengths for weathering short-term volatility.

Bearish Takeaways

  • Bearish analysts note that escalating U.S. tariffs have led to more significant cost headwinds than previously anticipated. This has put pressure on profitability and valuation multiples.
  • There is concern over slower growth assumptions, as the revised price targets factor in a more prolonged impact from global trade dynamics.
  • Uncertainty regarding how quickly SEB can implement operational adjustments has led to downgrades. Execution risk remains elevated in the near term.

What's in the News

  • Groupe SEB has provided sales guidance for the third quarter of 2025, expecting a slight organic decline and results below the company’s forecasts (Key Developments).
  • The company revised its full-year 2025 earnings guidance, now anticipating stable to slightly positive organic sales growth compared to the previously expected 2% to 4%. Operating results from activity are forecasted at €550 million to €600 million, which is lower than the earlier forecast of €700 million to €750 million (Key Developments).
  • SEB SA also lowered its annual organic sales growth outlook for 2025, now targeting a range of 2% to 4% instead of the earlier projection of around 5% (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has fallen significantly from €101.60 to €85.10, reflecting reduced confidence in near-term growth and profitability.
  • Discount Rate has risen slightly, increasing from 10.40% to 10.93%. This suggests a higher perceived risk profile for SEB.
  • Revenue Growth expectations have been reduced from 4.15% to 3.03%. This indicates more conservative assumptions about future sales expansion.
  • Net Profit Margin forecast has decreased from 5.67% to 5.14%, pointing to anticipated pressures on profitability.
  • Future P/E (Price-to-Earnings) Ratio has fallen modestly from 14.19x to 13.73x. This signals a minor decline in SEB’s valuation multiple.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.